Found 1,117 investors
Stephen Forte
United States
Mr. Stephen Forte is a Co-Founder and serves as Managing Partner at Fresco Capital. He serves as Board Observer at LeadIQ. He serves as Board Member at Swivl and CircleLink Health. He served as a Board Member at Swipes. He serves as an Advisor at Catalia Health. He was also the Advisor at Launchpilots and Quark VR. He was a Co-Founder and served as Director at Mach5 Accelerator. Based in Menlo Park, CA, He is involved in all aspects of investment and operations with a specific focus on enterprise and IoT. Prior, he was Chief Strategy Officer of Telerik, a leading vendor of developer and team productivity tools and acquired by Progress Software in 2014. He is an active angel investor and also a mentor at several startup accelerators including Haxlr8r and the Thiel Foundation's 20 under 20 programs. He is the founder of Mach5, a Silicon Valley-based startup accelerator and co-founder of AcceleratorHK, Hong Kong's first startup accelerator. He was the co-founder of several startups, including Chassis Finder (acquired in 2012), Triton Works (acquired in 2010) and Corzine (acquired in 2007). Prior to Corzen, he served as the first CTO of venture-backed Zagat Survey in New York City (acquired in 2011) and also was the co-founder of the New York-based software consulting firm The Aurora Development Group. He has an MBA from the City University of New York, did post-grad work at LSE and has written several books on application and database development.
Individual/Angel
Past Investments
Chai, I Done This, Plukka Fine Jewelry, Makible, Compology, KITE, PayAllies, Taxiwise, Because Learning, MeetingPulse, STAND, Y5Zone, Riskpulse, Launchpilots, Boon Gable, SchoolMint, Little Bird, Red Clay, Insight Robotics
Steven King
Nashville, Tennessee, United States
Executive Director, BioTN - Life Science Tennessee Mentor Network
Individual/Angel
Seed
Past Investments
Restore Medical Solutions
Stuart Roden
United States
Mr. V. R. Kaundinya is an Angel Investor. He serves as Board Member at Axis Bank. He served as Board Member at Advanta Growth Capital. Ram Kaundinya is an expert in the field of agriculture and specifically with reference to the business of agricultural inputs. He has a total experience of about 36 years which includes 22 years in the agrochemical industry and 14 years in the seed and biotech industry. Mr Kaundinya was the Managing Director and CEO of Advanta Ltd, an Indian seed company with global foot print from 2006 to 2013. In this capacity he was responsible for running the global business spread across various continents. The area of operation extended from Australia in the East to Argentina in the West . He led the global leadership team consisting of senior managers from different countries. Travelled extensively across the world and got exposed to agriculture and agri input markets in different parts of the world. Prior to this Mr Kaundinya held many posts of responsibility which included Managing Director of Emergent Genetics India and Managing Director of Cyanamid Agro during which he led multifunctional teams consisting of research, manufacturing, finance, supply chain, HR and Sales & marketing in seeds and agrochemicals industries. Prior to this he also served as the Director of the Agricultural Products Division of Cyanamid India and also served Hoechst India for thirteen years as a senior member of the management team of their agrochemicals division. Starting with sales and marketing during the long career Mr Kaundinya handled General Management and P&L responsibility for the last 16 years. Mergers and Acquisitions was a major area of expertise that he developed especially in the last 14 years, having led his companies in multiple transactions across the world. Mr. Kaundinya has always been associated with various industry associations. He was the Chairman of the Crop Life India (the then Indian Crop Protection Association) for two years from1998-2000. He was the Director of the Association of Seed Industry (ASI), Mumbai from 2002 to 2006. He is currently the Director General of the Agricultural Group of the biotech industry association called ABLE. He has been at the forefront of the expansion of biotechnology applications in agriculture in India. He has a wide experience in the area of policy advocacy for agricultural input industry. Kaundinya holds a PGDM with specialization in Agriculture from Indian Institute of Management, Ahmedabad. He is a graduate in Agriculture from the Andhra Pradesh Agricultural University. Kaundinya has been involved with academics for the last 30 years. He is a frequent guest lecturer at various management institutes. He teaches courses in Marketing and Corporate Strategy. Mr Kaundinya is a writer. He has co-authored a book titled 'Agri Input Marketing in India' with Prof Venugopal of XLRI. The book is just released. He currently consults independently for companies and funds operating in the field of agriculture. Mr. Kaundinya serves as an independent director on the boards of Axis Bank, Axis Finance and Syngenta India and as a non-Executive Director on the board of Advanta Ltd.
Individual/Angel
Past Investments
Trigo, Anima App, Granulate, Mozper, retrain.ai, Codota, Jones, Acumen.io
Tobias Peggs
New York, New York, United States
Brit in NYC. Strengthening communities through #realfood as @squarerootsgrow CEO. Previously. @Aviary CEO (acquired by Adobe); @OneRiot CEO ...
Individual/Angel
Seed
Past Investments
Diem, UniqueSound
Touker Suleyman
London, England, United Kingdom
Touker Suleyman is a multi-millionaire Turkish Cypriot fashion retail entrepreneur and investor. In 2001, his company Low Profile Group purc...
Individual/Angel
Seed
Pre-Seed
Past Investments
Cablato, Personify XP
Vijay Ullal
United States
Dr. Stephen Pollitt is an Angel Investor. He served as Board Member at Sand Hill Angels. He has over 19 years experience in the biotechnology and pharmaceutical industries. His career began with Scios (later acquired by Johnson & Johnson) where he was in charge of host cell development for biologics heading into clinical testing. One of these products, Natrecor, received FDA approval in 2001 as a treatment for acute congestive heart failure. He served as Project Leader on several early phase drug discovery and development projects, most recently as Compound Development Team Lead for VEGF-121. He also served on the target selection committee which evaluated targets for the company's small molecule development platform. Steve is currently an independent consultant working with drug development teams at start-ups and virtual companies where he assists with management of the drug development process and molecular biology of protein expression. Steve holds a Ph.D. in Molecular Biology from Purdue University, West Lafayette, IN and a B.S. in Chemistry with honors from the University of Georgia. He was a postdoctoral fellow at SUNY, Stony Brook and a Research Assistant Professor at the University of Medicine and Dentistry of NJ in Piscataway.
Individual/Angel
Past Investments
NextForce Technology, PowWow Energy, 3TEN8, NeoReach, Focal Systems, RageOn, Datawallet, Rigetti Quantum Computing, Naked Labs, Rupertbot, Wyre, Axiom Exergy, Paysa, Cypherpath, Gravity Group previously Dil Mil, Polychain Capital, Voke VR, Labdoor, Ampool, Kemvi, Artinem
Ward Hills
Cambridge, Cambridgeshire, United Kingdom
Ward is an IOD certified director, entrepreneur and investor who is actively involved with a number of business in digital healthcare, biote...
Individual/Angel
Seed
Past Investments
PneumaCare
Will Coffield
Los Angeles, California
General Partner at Riot Ventures
Hardware
SMB Software
TransportationTech
Individual/Angel
Venture Capital
Seed
Past Investments
Think Through Learning, Chirpify, Simbe Robotics, YieldStreet, Alignable, Arrivo, Event Farm, System1, Trunomi, Panopto, Sentenai, Omaze, Kaleo Software
Zubair Quraishi
United States
Mr. John Allspaw is a Co-Founder of Adaptive Capacity Labs. He serves as Advisor and Investor at Signal Sciences. He served as Chief Technology Officer at Etsy. Previously, he was SVP of Infrastructure and Operations at Etsy. For over 17 years, he has worked in system operations in the biotech, government and online media industries. He began his career running vehicle crash simulations for the U.S. government. In 1997, he made the leap to the web, building the technical infrastructures at Salon, InfoWorld, Friendster and Flickr. John is the author of The Art of Capacity Planning and Web Operations: Keeping the Data On Time, both published by O'Reilly Media.
Individual/Angel
Past Investments
NemCV, Safello, Can Labs
021 Capital
Bangalore, Karnataka, India
021 Capital is a venture capital investment firm that invests biotechnology, agrotechnology, and the internet.
Venture Capital
Private Equity Firm
Venture Capital
10X Fund LP
Niceville, Florida, United States
10X Fund LP invests principally in the biotechnology sector and is a technology-focused hedge fund based in Florida.
Biotechnology
Finance
Venture Capital
Hedge Fund
1198 Trinity Ventures
India
Founded in 2021, 1198 Trinity Ventures is an accelerator and incubator firm based in Hyderabad, India. The firm targets Indian companies operating in artificial intelligence & cognition, advanced materials & manufacturing, biotechnology, energy advancements, microelectronics, quantum computing, and autonomy sectors.
Accelerator
Incubator
30Ventures
Madison, Wisconsin, United States
30Ventures is an early-stage healthcare and biotechnology venture capital firm.
Angel Investment
Biotechnology
Health Care
Venture Capital
Venture Capital
365^x Accelerator
Kfar Saba, HaMerkaz, Israel
The 365x Accelerator is a business enhancer for Software and IoT Startup Companies.
Consulting
Information Technology
Software
Accelerator
3B Future Health Ventures
Luxembourg
Founded in 2016, 3B Future Health is a venture capital firm based in Luxembourg, Luxembourg. The firm focuses on privately-owned companies with early-stage technologies in oncology, biotechnology, pharmaceutical, medical devices, and food supplements. The firm supports US and European-based private early-stage, innovative companies in areas of high unmet patient need with focus on oncology and rare disease therapeutics. The firm's investment team brings together experience across the healthcare industry and includes senior leaders with solid expertise in drug discovery, research and development, drug manufacturing, corporate and business development, as well as investment fund management. The Fund supports companies with potential first-in-class assets, revolutionary ideas, experienced management teams and a strong investor syndicate. The Fund typically makes its initial investment in companies raising Series A rounds, but in some cases, invests even earlier.
Venture Capital
3D Printing Ventures
United States
Founded in 2007, 3D Printing Ventures is a venture capital firm based in New York, New York. The firm prefers to invest in 3D printing companies, Biotech, Education, Eyewear, Health, Manufacturing, Media, Technology, and Entertainment sectors.
Venture Capital
5G Open Innovation Lab
United States
5G Open Innovation Lab is an acceleration firm based in Bellevue, Washington. The firm is a global ecosystem for developers, enterprises, wireless carriers, and technology leaders to research, prototype, and test new technologies, applications, and use cases based on 5G network capabilities. The firm focuses on unifying the ecosystem covering all aspects of the 5G ecosystem from devices, edge, internet of things, applications, and the cloud. The firm expects new private enterprise network concepts leveraging 5G speeds, latency, and capacity that will contribute to new IoT solutions in manufacturing, healthcare, agriculture, transport & logistics, autonomous vehicles, energy utility, media & entertainment, space & satellite, and retail sectors.
Accelerator
Incubator
5of5 Venture Capital
United States
Founded in 2022, 5of5 Venture Capital is a venture capital firm based in California, United States. The firm seeks to invest in companies operating in the SaaS, e-commerce, mobile, wearables & IoT, logistics, fintech, and APIs sectors.
Venture Capital
618 Ventures
United States
Founded in 2018, 618 Ventures is a venture capital firm based in Solana Beach, California. The firm seeks to make minority investments in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare devices, healthcare services, biotechnology, pharmaceuticals, health tech, life sciences, and big data sectors.
Venture Capital
Abaco Ventures
United States
Abaco Ventures is an investment firm based in Huntsville, Alabama. The firm mainly focuses on single family homes in the city of Huntsville and Madison. It also has investments concentrated in the Southeast United States and Bahamas with specialized areas of interest include biotech, real estate and growth technology companies.
Venture Capital
Showing 101 to
120 of
1,117 results